Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, the second-largest drug-marketing ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures. The ...

Abbott Laboratories said on Monday it agreed to pay $1.6 billion to resolve civil and criminal allegations related to the promotion of anti-seizure drug Depakote for unapproved uses.

JEFFERSON CITY — Missouri will get more than $15 million from a national settlement with Abbott Laboratories involving the marketing of the drug Depakote. Depakote is an anti-seizure and mood ...

Abbott Laboratories Inc will pay $1.6 billion to resolve civil and criminal allegations that it promoted anti-seizure drug Depakote for uses that were not approved by U.S. health regulators, the ...

Caldwell’s office filed a lawsuit in 2011 against Abbott, alleging the company misbranded Depakote, an anti-epileptic medication. Abbott allegedly promoted the drug to control.

ABBOTT PARK, Ill. – Abbott Laboratories agreed Monday to pay $1.6 billion after dozens of state and federal authorities sued over its off-label promotion of the anti-seizure drug Depakote. The ...

Abbott Pleads Guilty To Misbranding; Will Pay $1.6 Billion - 05/08/2012. ... Drug and Cosmetic Act for "misbranding" the drug Depakote. ...

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures.

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures.